Clinical Trial Update: Single-arm, Open-label Clinical Study of SZ003 in the Treatment of Advanced Hepatocellular Carcinoma [NA]

View source ↗

Summary

A single-arm, open-label study of SZ003 for advanced hepatocellular carcinoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• SZ003

Snippet

Sponsor: Shantou University Medical College | Conditions: Advanced Hepatocellular Carcinoma | NA | Status: TERMINATED